Recent content by data-driven

Been hearing more about this lately, people on GLP1s reporting real shifts in other addictive behaviors too, drinking, smoking, even gambling showing up in some of these stories.

Same here, though it's not as often anymore. Loading up on fiber and protein doesn't do much for it. Usually I just grab some bread or pasta and that helps more.

Started near your weight and same pattern - first 20 quick and then slowing to half a pound a week. Frustrating but still moving. The 56 in the OP is what staying in it through the slow phase looks like. What dose are you on?

The reddit comment section direction on someone's injection frequency is exactly the kind of thing that happens when people apply generic rules to individual protocols. The OP's insurance stopping coverage and going the peptide path is a specific situation with its own logic. What was the main...

the 3x per week strength recommendation is solid for someone who is new to resistance training and already doing cardio - the frequency is enough to produce muscle adaptation and metabolic benefit without requiring the recovery capacity of daily training. the movement-easier-in-later-life...

32g 4mm pen needles are designed for subcutaneous use - they're too short to reliably reach muscle tissue in most injection sites for intramuscular delivery. For actual IM injections, 25-27g at 1 inch is the minimum that consistently reaches muscle in typical sites.

Going off Tirz cold after exactly a year without washout and managing maintenance is worth the detailed note. The fact that you didn't regain immediately tells us something about what was sustainable in the behavioral changes alongside the medication. How's the year-plus maintenance picture...

The 'critical and judgemental no matter what' observation about weight and social media is one of those things you can't unsee once you notice it. The person trying to lose is criticized for the method, the person succeeding is questioned about sustainability, the person maintaining is asked...

The zero research on Reta and T1D makes sense given how different the mechanism considerations are - glucagon pathway effects matter differently when insulin production is already compromised. The Tirzepatide T1D data is at least a starting point for comparison. What dose are you looking at and...

the Medicare will-cover-a-panniculectomy-but-not-the-medication situation is one of the stranger coverage logic inversions - the surgical intervention for the end-stage complication is covered but the medication that prevents reaching that stage is not. the coverage gap tends to close once the...

The OR conversation situation is its own kind of medical ethics issue beyond the medication judgment. The hypocrisy of finding out someone who was vocal about it was also on the medication is almost too on-the-nose. The stigma is real but clearly not universally held even in the circles of...

Maintenance after reaching goal and answering the 'will you ever stop' question with intent to continue is the right frame for a medication that's correcting metabolic function. The OP's pre-diabetic conversion to healthy markers is the same story. How long did it take to reach goal and what...

Skin sensitivity at 4mg very hard to tolerate and then at 8mg only showing up when cold is the dose-adaptive pattern that's worth knowing about. The OP's sun sensitivity question is in the same neighborhood - threshold effects that come and go rather than constant. What's the dose timeline from...

32 lbs at .50mg and now in maintenance without needing to go higher is the efficient version of the story. Staying at .25 for 6 weeks to build tolerance before bumping is the patient approach that usually makes the side effect profile cleaner. The OP's 20+ lbs at month 4 is on a similar trajectory.

the compound naming variation across sources is genuinely confusing for new users - the same molecule can carry different abbreviations depending on which community or supplier convention you're reading. keeping the full chemical or generic name as the reference anchor and treating abbreviations...